Spotlight
Clinical Role
Clinical
Supplement Spotlight
CME/CE
CLL: Treatment Paradigm Shifts and Impact on Outcomes
Kirollos S. Hanna, PharmD, BCPS, BCOP, provides an overview of the shifts in treatments, trends, and outcomes seen over the past decade in CLL.
Now Viewing
EP: 1.CLL: Treatment Paradigm Shifts and Impact on Outcomes
EP: 2.NCCN Guidelines: Rapid Change in CLL Treatment Concepts
EP: 3.Therapy Initiation and Treatment Goals in CLL
EP: 4.Long-Term Data on the Use of BTK Inhibitors in CLL
EP: 5.Toxicity Management for BTK Inhibitors: Pharmacist’s Role
EP: 6.Head-to-Head BTK Inhibitor Data and Cardiovascular Toxicity
EP: 7.BTK Inhibitor in Combination With Anti-CD20 mAb for CLL
EP: 8.BCL2 Inhibitor in Combination With Anti-CD20 mAb for CLL
EP: 9.BTKi-Based Vs BCL2i-Based Regimens in CLL
EP: 10.Emerging Therapies in CLL
EP: 11.Advice for Optimizing Treatment Success in CLL
Related Videos
